Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticancer drug discovery by targeting cullin neddylation
Qing Yu, Yihan Jiang, Yi Sun
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 5, pp. 746-765
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Protein neddylation and its role in health and diseases
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 39
The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer
Nicole E. Pellegrino, Arcan Güven, Kayleigh Gray, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3480-3480
Open Access | Times Cited: 38
Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions
Dong‐Jun Fu, Ting Wang
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 24
Targeting neddylation E2s: a novel therapeutic strategy in cancer
Yi‐Chao Zheng, Yan-Jia Guo, Bo Wang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 42
A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer
Tiantian Xu, Qisheng Ma, Yanan Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 31
Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formation
Lingfeng Zhong, Jibo Han, Xiaoxi Fan, et al.
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Closed Access | Times Cited: 19
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential
Jan Jakub Lica, Bhaskar Pradhan, Kawthar Safi, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4280-4280
Open Access | Times Cited: 6
Phosphorylation regulates cullin-based ubiquitination in tumorigenesis
Yifan Chen, Xuejing Shao, Ji Cao, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 2, pp. 309-321
Open Access | Times Cited: 48
Diverse and pivotal roles of neddylation in metabolism and immunity
Tao Zou, Jiyan Zhang
FEBS Journal (2020) Vol. 288, Iss. 13, pp. 3884-3912
Open Access | Times Cited: 45
Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis
Yang Su, Yifan Luo, Peitao Zhang, et al.
Molecular Cell (2023) Vol. 83, Iss. 13, pp. 2316-2331.e7
Closed Access | Times Cited: 15
Targeting cullin neddylation for cancer and fibrotic diseases
Zhangxu He, Wei-guang Yang, Dan Zengyangzong, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 5017-5056
Open Access | Times Cited: 13
Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)
Yuran Qiu, Xinyi Li, Xinheng He, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112764-112764
Closed Access | Times Cited: 35
A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1)
Zhanxia Zhang, Junqian Zhang, Jianhui Tian, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Pan-cancer analysis unveils the role and mechanisms of neddylation modifications in tumorigenesis
Qin Hu, Xiang Li, Ping Wang, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Neddylation and MASLD: From Pathophysiology to Therapy
Wenjun Lin, Wenfang Zheng, Ning Dai, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Discovery of a small molecule inhibitor of cullin neddylation that triggers ER stress to induce autophagy
Yanan Li, Chaorong Wang, Tiantian Xu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3567-3584
Open Access | Times Cited: 25
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma
Iris C. Salaroglio, Dimas Carolina Belisario, Paolo Bironzo, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 17
Machine learning-based neddylation landscape indicates different prognosis and immune microenvironment in endometrial cancer
Yi Li, Jiang-Hua Niu, Yan Wang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Enhanced Cytotoxic Activity of PEGylated Curcumin Derivatives: Synthesis, Structure–Activity Evaluation, and Biological Activity
Dawid Łażewski, Małgorzata Kucińska, Edward Potapskiy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1467-1467
Open Access | Times Cited: 9
Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma
H. N. Abramson
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2645-2645
Open Access | Times Cited: 9
Triaging between post-translational modification of cell cycle regulators and their therapeutics in neurodegenerative diseases
Neetu Rani, Mehar Sahu, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2023) Vol. 94, pp. 102174-102174
Closed Access | Times Cited: 9
Neddylation Regulation of Immune Responses
Hongmei Mao, Xin Lin, Yi Sun
Research (2023) Vol. 6
Open Access | Times Cited: 8
Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers
Jian Song, Yuan Liu, Xin-Ying Yuan, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113801-113801
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top